Capricor Therapeutics (CAPR) Non-cash Items (2012 - 2024)
Capricor Therapeutics (CAPR) recorded quarterly Non-cash Items of $20.4 million in Q4 2024, up 22.89% quarter-over-quarter from $16.6 million in Q3 2024, and up 380.21% on a YoY basis from $4.2 million in Q1 2024.
Capricor Therapeutics (CAPR) Non-cash Items (2012 - 2024) Analysis & Trends
Capricor Therapeutics' Non-cash Items history runs 7 years deep, the most recent figure standing at $20.4 million for Q4 2024.
- In Q4 2024, Non-cash Items rose 380.21% year-over-year to $20.4 million; the TTM figure through Dec 2024 stood at $20.4 million (up 380.21% YoY), while the FY2024 annual figure was $20.4 million, up 380.21% from the prior year.
- Non-cash Items was $20.4 million for Q4 2024 at Capricor Therapeutics, up from $16.6 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $20.4 million in Q4 2024 to a low of $171000.0 in Q1 2020.
- Historically, Non-cash Items has averaged $6.4 million across 5 years, with a median of $4.2 million in 2020.
- The sharpest annual moves came in 2021 and 2022: Non-cash Items jumped 4812.28% in 2021, then plunged 77.01% in 2022.
- A 5-year view of Non-cash Items shows it stood at $4.2 million in 2020, then dropped by 26.72% to $3.1 million in 2021, then jumped by 225.32% to $10.1 million in 2022, then plunged by 57.94% to $4.2 million in 2023, then soared by 380.21% to $20.4 million in 2024.
- The last three Non-cash Items figures came in at $20.4 million (Q4 2024), $16.6 million (Q3 2024), and $5.5 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Capricor Therapeutics | 1.53 Bn | 1.26 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 20.40 Mn |
| Dec 31, 2024 | 20.40 Mn |
| Sep 30, 2024 | 16.60 Mn |
| Sep 30, 2024 | 16.60 Mn |
| Jun 30, 2024 | 5.52 Mn |
| Jun 30, 2024 | 5.52 Mn |
| Mar 31, 2024 | 5.00 Mn |
| Mar 31, 2024 | 5.00 Mn |
| Dec 31, 2023 | 4.25 Mn |
| Dec 31, 2023 | 4.25 Mn |
| Sep 30, 2023 | 3.86 Mn |
| Sep 30, 2023 | 3.86 Mn |
| Jun 30, 2023 | 3.43 Mn |
| Jun 30, 2023 | 3.43 Mn |
| Mar 31, 2023 | 15.20 Mn |
| Mar 31, 2023 | 15.20 Mn |
| Dec 31, 2022 | 10.10 Mn |
| Dec 31, 2022 | 10.10 Mn |
| Sep 30, 2022 | 2.26 Mn |
| Sep 30, 2022 | 2.26 Mn |